Concepedia
Author
Outi Lahdenperä
Also Known As
O. Lahdenpera, O. Lahdenperä, OUTI LAHDENPERÄ, Outi Lahdenperä
11
Publications
311
Citations
7
H-Index
0
Concepts
All Affiliations
×
All Concepts
303
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer
Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, +15
JAMA Oncology
2017
91
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
David Miles, Eva Ciruelos, Fabio Puglisi, +230
Annals of Oncology
2021
83
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer
Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala, +7
Clinical Breast Cancer
2019
51
High baseline Tie1 level predicts poor survival in metastatic breast cancer
Leena Tiainen, Emilia A. Korhonen, Veli‐Matti Leppänen, +11
BMC Cancer
24
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer
Leena Tiainen, Minna Tanner, Outi Lahdenperä, +6
Anticancer Research
2016
22
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
Karin Holmsten, Niels Viggo Jensen, Lene Sonne Mouritsen, +14
European Journal of Cancer
Adjuvant capesitabine in combination with docetaxel (T), epirubicin (E), and cyclophosphamide (C) in the treatment of early breast cancer (BC): 10-year survival results from the randomized FinXX trial.
Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, +13
Journal of Clinical Oncology
10
Page 1